PROCAPS GROUP

Procaps Group, S.A. ("Procaps Group") (NASDAQ: PROC) is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5.000 collaborators working under a sustainable model. Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions... MIAMI & BARRANQUILLA, Colombia --(BUSINESS WIRE)--Mar. 4, 2024-- Procaps Group (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated Latam healthcare and pharmaceutical services company, today announced that it is conducting a process to explore strategic alternatives to maximize... Founded in 1977, Procaps is leading integrated international healthcare and pharmaceutical company that develops pharmaceutical and nutraceutical solutions, medicines..

Also known as: Procaps, Procaps Group Company, Procaps Group, S.A., PROCAPS S.A., Procaps Salvador, S.A.

Primary location: Luxembourg Luxembourg